IL6 and type 2 diabetes mellitus: The development of chronic, low-grade systemic inflammation is present early in both T2D and obesity, where pro-inflammatory cytokines are released from M1-type macrophages (TNF-α, IL-6, IL-12, IL-18) [36,37,40,41].